A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections

Paul Lloyd1, Anne Hong2, Marc A. Furrer2, Elaine W Y Lee1, Harveer Dev1, Maurice H Coret1, James Adshead3, Peter Baldwin4, Richard Knight1, Jonathan Shamash5, Constantine Alifrangis6, Sara Stoneham6, Danish Mazhar7, Hock Tsen Wong7, Anne Y. Warren8, Ben Tran9, Nathan Lawrentschuk2, David E. Neal1, Benjamin Thomas10
1Department of Urology, Addenbrooke’s Hospital, Cambridge University Hospitals, Cambridge, UK
2Department of Urology, Royal Melbourne Hospital, Melbourne, Australia
3Department of Urology, Lister Hospital, Stevenage, UK
4Department of Gynae-Oncology, Addenbrooke’s Hospital, Cambridge, UK
5Department of Oncology, St Bartholomew’s Hospital, London, UK
6Department of Oncology, University College London Hospital, London, UK
7Department of Oncology, Addenbrooke’s Hospital, Cambridge University Hospitals, Cambridge, UK
8Department of Pathology, Addenbrooke’s Hospital, Cambridge University Hospitals, Cambridge, UK
9Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
10The Australian Medical Robotics Academy, Melbourne, Australia

Tóm tắt

Từ khóa


Tài liệu tham khảo

Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA et al (2009) NCCN clinical practice guidelines in oncology: testicular cancer. J Natl Compr Canc Netw 7(6):672–693

Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K et al (2015) Guidelines on testicular cancer: 2015 update. Eur Urol 68(6):1054–1068

Chalfin HJ, Ludwig W, Pierorazio PM, Allaf ME (2016) Robotic primary RPLND for stage I testicular cancer: a review of indications and outcomes. Curr Urol Rep 17(5):41

Williams SB, McDermott DW, Winston D, Bahnson E, Berry AM, Steele GS et al (2010) Morbidity of open retroperitoneal lymph node dissection for testicular cancer: contemporary perioperative data. BJU Int 105(7):918–921

Rukstalis DB, Chodak GW (1992) Laparoscopic retroperitoneal lymph node dissection in a patient with stage 1 testicular carcinoma. J Urol 148(6):1907–1909 (discussion 9-10)

Steiner H, Leonhartsberger N, Stoehr B, Peschel R, Pichler R (2013) Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients. Eur Urol 63(6):1013–1017

Cheney SM, Andrews PE, Leibovich BC, Castle EP (2015) Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients. BJU Int 115(1):114–120

Pearce SM, Golan S, Gorin MA, Luckenbaugh AN, Williams SB, Ward JF et al (2017) Safety and early oncologic effectiveness of primary robotic retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer. Eur Urol 71(3):476–482

Davol P, Sumfest J, Rukstalis D (2006) Robotic-assisted laparoscopic retroperitoneal lymph node dissection. Urology 67(1):199

Revenig L, Leung A, Hsiao W (2014) Ejaculatory physiology and pathophysiology: assessment and treatment in male infertility. Transl Androl Urol 3(1):41–49

Katz A, Dizon DS (2016) Sexuality after cancer: a model for male survivors. J Sex Med 13(1):70–78

Stepanian S, Patel M, Porter J (2016) Robot-assisted laparoscopic retroperitoneal lymph node dissection for testicular cancer: evolution of the technique. Eur Urol 70(4):661–667

Overs C, Beauval JB, Mourey L, Rischmann P, Soulie M, Roumiguie M et al (2018) Robot-assisted post-chemotherapy retroperitoneal lymph node dissection in germ cell tumor: is the single-docking with lateral approach relevant? World J Urol 36(4):655–661

Harris KT, Gorin MA, Ball MW, Pierorazio PM, Allaf ME (2015) A comparative analysis of robotic vs laparoscopic retroperitoneal lymph node dissection for testicular cancer. BJU Int 116(6):920–923

Mosharafa AA, Foster RS, Koch MO, Bihrle R, Donohue JP (2004) Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol 171(5):1839–1841

Cary C, Masterson TA, Bihrle R, Foster RS (2015) Contemporary trends in postchemotherapy retroperitoneal lymph node dissection: Additional procedures and perioperative complications. Urol Oncol 33(9):389.e15–21

Kamel MH, Littlejohn N, Cox M, Eltahawy EA, Davis R (2016) Post-chemotherapy robotic retroperitoneal lymph node dissection: institutional experience. J Endourol 30(5):510–519

Singh A, Chatterjee S, Bansal P, Bansal A, Rawal S (2017) Robot-assisted retroperitoneal lymph node dissection: feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 33(4):304–309

Abdul-Muhsin HM, L’Esperance JO, Fischer K, Woods ME, Porter JR, Castle EP (2015) Robot-assisted retroperitoneal lymph node dissection in testicular cancer. J Surg Oncol 112(7):736–740

Darzi SA, Munz Y (2004) The impact of minimally invasive surgical techniques. Annu Rev Med 55:223–237

Tang K, Xia D, Li H, Guan W, Guo X, Hu Z et al (2014) Robotic vs. open radical cystectomy in bladder cancer: a systematic review and meta-analysis. Eur J Surg Oncol 40(11):1399–1411

Son SK, Lee NR, Kang SH, Lee SH (2017) Safety and effectiveness of robot-assisted versus open radical cystectomy for bladder cancer: a systematic review and meta-analysis. J Laparoendosc Adv Surg Tech A 27(11):1109–1120

Shen Z, Xie L, Xie W, Hu H, Chen T, Xing C et al (2016) The comparison of perioperative outcomes of robot-assisted and open partial nephrectomy: a systematic review and meta-analysis. World J Surg Oncol 14(1):220

Yaxley JW, Coughlin GD, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L et al (2016) Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. Lancet 388(10049):1057–1066

Li R, Duplisea JJ, Petros FG, Gonzalez GMN, Tu SM, Karam JA et al (2019) Robotic postchemotherapy retroperitoneal lymph node dissection for testicular cancer. Eur Urol Oncol. https://doi.org/10.1016/j.euo.2019.01.014

Stein JP, Penson DF, Cai J, Miranda G, Skinner EC, Dunn MA et al (2007) Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 177(3):876–881 (discussion 81)

Beck SD, Foster RS, Bihrle R, Donohue JP, Einhorn LH (2007) Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor? Cancer 110(6):1235–1240

Carver BS, Shayegan B, Eggener S, Stasi J, Motzer RJ, Bosl GJ et al (2007) Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol 25(28):4365–4369

Cho JS, Kaimakliotis HZ, Cary C, Masterson TA, Beck S, Foster R (2017) Modified retroperitoneal lymph node dissection for post-chemotherapy residual tumour: a long-term update. BJU Int 120(1):104–108

Heidenreich A, Pfister D, Witthuhn R, Thuer D, Albers P (2009) Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection. Eur Urol 55(1):217–224